CINECA IRIS Institutional Research Information System

DI STILO, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.190
AS - Asia 3.598
EU - Europa 3.358
SA - Sud America 352
AF - Africa 89
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.626
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.036
SG - Singapore 1.334
CN - Cina 1.237
SE - Svezia 415
IE - Irlanda 414
DE - Germania 404
IT - Italia 391
FR - Francia 373
VN - Vietnam 351
UA - Ucraina 294
FI - Finlandia 285
BR - Brasile 276
GB - Regno Unito 238
KR - Corea 201
PL - Polonia 157
CA - Canada 117
IN - India 115
AT - Austria 105
HK - Hong Kong 77
JP - Giappone 68
NL - Olanda 57
BE - Belgio 41
RU - Federazione Russa 40
ID - Indonesia 37
IQ - Iraq 34
SN - Senegal 29
AU - Australia 26
MX - Messico 21
ES - Italia 20
AR - Argentina 19
BD - Bangladesh 19
RO - Romania 19
TR - Turchia 19
GR - Grecia 17
PK - Pakistan 15
CH - Svizzera 13
HU - Ungheria 13
TW - Taiwan 13
EC - Ecuador 12
LT - Lituania 12
ZA - Sudafrica 12
NZ - Nuova Zelanda 10
UZ - Uzbekistan 10
CL - Cile 9
CO - Colombia 9
CZ - Repubblica Ceca 9
IL - Israele 9
DK - Danimarca 8
VE - Venezuela 8
DZ - Algeria 7
HR - Croazia 7
JO - Giordania 7
MA - Marocco 7
PT - Portogallo 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
IR - Iran 6
IS - Islanda 6
KE - Kenya 6
MY - Malesia 6
PY - Paraguay 6
NO - Norvegia 5
TH - Thailandia 5
AZ - Azerbaigian 4
MU - Mauritius 4
PE - Perù 4
SA - Arabia Saudita 4
SC - Seychelles 4
TN - Tunisia 4
AM - Armenia 3
CR - Costa Rica 3
EU - Europa 3
KZ - Kazakistan 3
BG - Bulgaria 2
BH - Bahrain 2
BJ - Benin 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
JM - Giamaica 2
MD - Moldavia 2
ML - Mali 2
NG - Nigeria 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
PH - Filippine 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AL - Albania 1
BY - Bielorussia 1
CV - Capo Verde 1
CY - Cipro 1
GN - Guinea 1
GT - Guatemala 1
HN - Honduras 1
IM - Isola di Man 1
KG - Kirghizistan 1
KW - Kuwait 1
Totale 13.620
Salva come PNG Salva come JPEG
Città #
Singapore 713
Chandler 610
San Jose 583
Beijing 547
Dublin 411
Ashburn 394
Ann Arbor 359
Santa Clara 266
Fairfield 239
Jacksonville 181
Warsaw 148
Los Angeles 138
Houston 137
Dearborn 136
Villeurbanne 130
Woodbridge 128
Medford 119
Princeton 118
Wilmington 118
Nyköping 116
Buffalo 114
Munich 111
Dallas 106
Vienna 102
Seattle 98
Pisa 92
The Dalles 89
Columbus 85
Lauterbourg 83
Dong Ket 81
Cambridge 77
Ho Chi Minh City 76
Hanoi 75
Council Bluffs 70
Helsinki 68
Shanghai 61
Torino 61
Hong Kong 56
New York 53
Redwood City 53
Guangzhou 51
Milan 48
Fremont 47
Boston 44
Boardman 42
Brussels 39
Tokyo 38
Rome 37
Nanjing 33
Toronto 31
São Paulo 30
Jakarta 29
Hangzhou 28
Ottawa 28
Nuremberg 25
Amsterdam 23
Frankfurt am Main 23
Seoul 23
Düsseldorf 22
Hefei 21
Washington 21
Jinan 20
Turku 20
Falls Church 19
Norwalk 19
Orem 18
Phoenix 17
Pune 17
Verona 17
Lachine 15
Mumbai 15
Philadelphia 15
San Diego 15
Shenyang 15
Stockholm 14
Baghdad 13
Silver Spring 13
Chennai 12
Groningen 12
Montreal 12
Zhengzhou 12
Atlanta 11
Melbourne 11
Chicago 10
Harbin 10
Paris 10
Turin 10
Belo Horizonte 9
Chengdu 9
Curitiba 9
London 9
Madrid 9
Poplar 9
Wuhan 9
Xian 9
Changsha 8
Chongqing 8
Da Nang 8
Kunming 8
Manchester 8
Totale 8.369
Salva come PNG Salva come JPEG
Nome #
Electrophilic Warhead-Based Design of Compounds Preventing NLRP3 Inflammasome-Dependent Pyroptosis 805
Stable Oxidative Cytosine Modifications Accumulate in Cardiac Mesenchymal Cells from Type2 Diabetes Patients: Rescue by alpha Ketoglutarate and TET-TDG Functional Reactivation 566
1,1-Dinitroethyl substituted furoxans : a new class of vasodilators and inhibitors of platelet aggregation 426
Validation of a GC/MS method for the detection of two quinoline-derived selective androgen receptor modulators in doping control analysis 291
(Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins 275
New nitric oxide or hydrogen sulfide releasing aspirins 274
Effects of Nitric Oxide Donor Antioxidants Containing the Phenol Vitamin E Substructure and a Furoxan Moiety on Ischemia/Riperfusion Injury 244
A new class of NO-donor H3-Antagonists 222
Development of a new class of potential antiatherosclerosis agents: NO-donor antioxidants 220
Nitrooxymethyl-Substituted Analogues of Rofecoxib: Synthesis and Pharmacological Characterization 217
Design, Synthesis and Pharmacological Evaluation of Anti-Pyroptotic Compounds Acting on NLRP3 Inflammasome Signaling Pathway: a New Start for Anti-Inflammatory Drugs? 213
Fast gaschromatographic/mass spectrometric determination of diuretics and masking agents in human urine. Development and validation of a productive screening protocol for antidoping analysis 209
A LIPOPHILIC NITRIC OXIDE-DONOR AND A LIPOPHILIC ANTIOXIDANT COMPOUND PROTECT RAT HEART AGAINST ISCHEMIA-REPERFUSION INJURY IF GIVEN AS HYBRID MOLECULE BUT NOT AS A MIXTURE. 208
Microwave-assisted synthesis of N-heterocycles in medicinal chemistry 205
Amphiphilic NO-Donor Antioxidants 198
Nitrooxymethyl Substituted Analogues of Celecoxib: Synthesis and Pharmacological Characterization 197
Multitarget Drugs: Synthesis and Preliminary Pharmacological Characterization of Zileuton Analogues Endowed with Dual 5-LO Inhibitor and NO-Dependent Activities 196
ALPHA(1)-ADRENOCEPTOR BLOCKING ACTIVITY OF SOME RING-OPEN ANALOGS OF PRAZOSIN 191
Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs) 185
Use of Nitric Oxide Releasing Furoxan System in the Design of "Hybrids": Substitution of Furoxan Moieties for the Furan Ring in Prazosin 183
Applicazione di una tecnica innovativa alle analisi per i controlli antidoping: determinazione di diuretici mediante fast-GC/MS 182
Non-conventional extractions and antioxidant properties evaluation of microalga Spirulina maxima 182
Cardiac Epi-Metabolic Signature Revealed by Integrated Omics Approach in Diabetic Patients: Rescue by Active DNA Demethylation via TET-TDG Complex Reactivation 180
Synthesis of Some Novel Organic Nitrates and Comparative in Vitro Study of Their Vasodilator Profile 172
Multitarget Drugs: Focus on the NO-donor hybrid drugs 165
NO-Donor Phenols: A New Class of Products Endowed with Antioxidant and Vasodilator Properties 163
Use of the Morita-Baylis-Hillman reaction in the design of compounds inhibiting NLRP3 inflammasome signaling pathways 160
[3-(1H-Imidazol-4-yl)propyl)guanidines Containing Furoxan Moieties: A New Class of H3-Antagonists Endowed with NO-Donor Properties 155
Characterisation of Furoxancarbonitriles as a New Class of Vasodilators 155
Anti-Helicobacter pylori Agents Endowed with H2-antagonist Properties 152
Targeting NLRP3 inflammasome regulatory mechanisms: design of anti-pyroptotic compounds for autoinflammatory diseases 152
SAR STUDIES ON H2 ANTAGONISTS CONTAINING ALKYLAMINO SUBSTITUTED 1,2,5-THIADIAZOLE 1-OXIDE MOIETIES 152
NO-donors: focus on furoxan derivatives 151
New organic nitrate-containing benzyloxy isonipecotanilide derivatives with vasodilatory and anti-platelet activity 149
CC1000: a new cardioprotective agent against ischemia/reperfusion injuries 148
"Enabling Technologies": a Step ahead in the Synthesis of Nitrogen-Containing Heterocycles 144
Synthesis and preliminary evaluation of model compounds targeting the NLRP3 inflammasome pathways 144
Combined protective effect of nitric oxide donor and antioxidants in the rat heart 142
Synthesis and Structure of a Trimer of the Furoxan System with High Vasodilator and Platelet Antiaggregatory Activity 142
New potential uroselective NO-donor a1-antagonists 141
Furoxan analogues of the histamine H3-receptor antagonist imoproxifan and related furazan derivatives 136
New 1,4-Dihydropyridines Conjugated to Furoxanyl Moieties, endowed With both NO-like and Ca2+ Channel Antagonist Vasodilator Activities 133
Recent advances in the cyclization of N-heterocycles: the role of enabling techniques 132
Pharmacochemistry of the Furoxan Ring : Recent Developments 129
Identification of Small Synthetic Anti-Pyroptotic Compounds 128
Novel Organic Nitrate Esters 127
Furoxan derivatives as NO-donors 127
Cytotoxic Activity of a Series of Heteroaryl-ONN-azoxysulphones and Arylsulphonylhydrazones 126
WATER SOLUBLE FUROXAN DERIVATIVES AS NO PRODRUGS 118
Mass spectrometry of quinolinone-derived selective androgen receptor modulators (SARMs) 118
Studies on New Basic NO-Donor 1,4-Dihydropyridines 116
Searching for Balanced Hybrid NO-Donor 1,4-Dihydropyridines with Basic Properties 115
Synthesis and structural characterization of the trimeric furoxan (equals furazan 2-oxide) system, a new potent vasodilating moiety 115
Effetto del post-condizionamento farmacologico sui danni da ischemia e riperfusione 115
Cyano-NNO-azoxy Analogs of Nifedipine 115
Furoxans as Nitric Oxide Donors. 4-Phenyl-3-furoxancarbonitrile: Thiol-Mediated Nitric Oxide Release and Biological Evaluation 113
L'effetto protettivo di un ibrido con proprietà antiossidante e NO donatrice contro i danni da ischemia e riperfusione nel cuore isolato di ratto 111
Synthesis and H2-Antagonist Properties of some 1,2,5-Thiadiazole-1-oxide Derivatives 111
Unsymmetrically Substituted Furoxans. Part 11. Methylfuroxancarbaldehydes 106
Low concentrations of an nitric oxide-donor combined with a liposoluble antioxidant compound enhance protection against reperfusion injury in isolated rat hearts 104
Furan and Thiophene analogues of omeprazole 104
Nitric oxide and antioxidant activity in the protection of the heart ischemia/reperfusion injury 101
Synthesis and Pharmacological Evaluation of Novel H3 Antagonists Endowed with NO-Donor Properties 100
The Cyano-NNO-Azoxy Function in the Design of an Irreversible Label for a1 Adrenoreceptors 100
Myocardial protection in the rat heart and role of weak and strong NO-release from a hybrid molecule containing an antioxidant substructure 98
In Vitro Cytotoxic Activity of Aryl and Heteroaryl-ONN-Azoxycyanides 97
NO donor - melatonins: a new class of potential antiatherosclerosis agents 93
Nitric oxide release by an edavarone derivative containing NOdonor furoxan moiety contributes to the resolution of renal injury after ischemia/reperfusion in the rat 90
Synthesis, chiral HPLC resolution and configuration assignment of 1-phenylglyceryl trinitrate stereomers 86
STUDIES ON AGENTS WITH MIXED NO-DEPENDENT VASODILATING AND β-BLOCKING ACTIVITIES 86
Studies on Agents with Mixed NO-Dependent and Calcium Channel Antagonistic Vasodilating Activities. 84
Use of Nitric Oxide Releasing Furoxan System in the Design of Hybrids With mixed NO-like Vasodilator Activity and *1-Antagonistic Properties 82
Fast gas-chromatography coupled mass spectrometry: rapid determination of diuretics in doping analysis 82
Non-imidazole histamine NO-donor H3-antagonists 80
LIPOPHILIC NO-DONOR AND LIPOPHILIC ANTIOXIDANT COMPOUND IN MYOCARDIAL PROTECTION AGAINST ISCHEMIA-REPERFUSION INJURY 80
Pyrazole analogues of prazosin 79
New 1,4-dihydropyridines endowed with NO-donor and calcium channel agonist properties 79
New NO-donor Bisphosphonates 78
High-speed gas-chromatography in doping control analyses: fast GC, ultrafast GC and fast GC/MS determination of Doping Substances 77
The Furoxan System as a Useful Tool to Balancing "Hybrids" with mixed alfa1-Antagonist and NO-Like Vasodilator Activities 76
Synthesis and vasodilating properties of N-alkylamide derivatives of 4-amino-3-furoxancarboxylic acid and related azo derivatives 76
Studies of the potential genotoxic effects of furoxans: the case of CAS 1609 and of the water soluble analogue of CHF 2363 76
NO donor and biological properties of different benzofuroxans. 75
Validation of a GC/MS method for the detection of two quinolinone-derived selective androgen receptor modulators in doping control analysis 75
The Furoxan System: Design of Selective Nitric Oxide (NO) Donor Inhibitors of COX-2 Endowed with Anti-Aggregatory and Vasodilating Activities 74
Vasodilating profile of a new series of analogues of GTN 73
New Uroselective NO-Donor a1-antagonists 70
Post-conditioning with NO-donors and antioxidant compounds 70
Tolerance profile of new organic nitrates with antioxidant properties 70
High-speed gas chromatography in doping control: Fast-GC and fast-GC/MS determination of beta-adrenoceptor ligands and diuretics 69
Physicochemical profile and in vitro permeation behavior of a new class of non-steroidal anti-inflammatory drug candidates 68
In vitro and in vivo vasodilating activity of nitroso derivatives gem -substituted with electron-withdrawing groups. 66
Michael addition of Grignard reagents to tetraethyl ethenylidenebisphosphonate 66
Nitric oxide (NO) donor beta(2)-agonists:furoxan derivatives containing the fenoterol moiety and related furazans 65
Nicorandil analogues containing NO-donor furoxans and related furazans 65
Simultaneous ultrasound-assisted water extraction and β-cyclodextrin encapsulation of polyphenols from Mangifera indica stem bark in counteracting TNFα-induced endothelial dysfunction 61
Potential Histamine H2-receptor Antagonists: Synthesis and Pharmacological Activity of Derivatives Containing Acylaminofurazan moieties 46
Totale 13.968
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.209
article - articoli 0
book - libri 0
conference - conferenze 9.903
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.112
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021186 0 0 0 0 0 0 0 0 0 0 47 139
2021/20221.307 40 40 63 85 98 16 142 83 43 164 267 266
2022/20231.675 207 167 60 168 135 389 211 98 125 31 50 34
2023/2024631 76 90 47 32 60 106 20 37 4 27 38 94
2024/20251.821 13 119 91 184 398 93 43 98 260 131 133 258
2025/20263.657 391 158 337 463 451 242 624 132 272 514 73 0
Totale 13.968